Hydroxycut Lawsuit Consolidation Request Scheduled for MDL Panel Hearing

|

A hearing before the U.S. Judicial Panel on Multidistrict Litigation is scheduled for later this month to determine whether all federal Hydroxycut lawsuits filed in various courts throughout the country should be centralized and consolidated before one judge for pretrial litigation as part of an MDL, or Multidistrict Litigation.

Hydroxycut, which was made by Iovate Health Sciences, is a dietary supplement and weight-loss aid that was recalled on May 1, 2009, after the FDA identified a number of reports where users suffered serious and potentially life-threatening liver damage. The FDA also reported that use of Hydroxycut was linked to reports of seizures, heart problems and a rare muscle damaging condition known as rhabdomyolysis.

Since the Hydroxycut recall, at least 17 lawsuits have been filed against Iovate Health Sciences over injuries allegedly caused by Hydroxycut side effects. The cases are currently pending in 13 different federal district courts, containing similar allegations that Iovate Health Sciences failed to adequately research their products or warn about the potential risks.

Hair-Dye-Cancer-Lawsuits
Hair-Dye-Cancer-Lawsuits

Some plaintiffs have filed a motion asking that all of the cases be consolidated into an MDL, where one judge will preside over the coordinated pretrial proceedings. An MDL is designed to avoid inconsistent pretrial rulings, repeat discovery on issues that are common to all cases and to serve the convenience of the parties, the witnesses and the court.

The plaintiffs who brought the request have proposed that the cases be centralized in the U.S. District Court for the Southern District of California, where three of the cases are currently pending.

Oral arguments from plaintiffs and defendants will be heard by the U.S. Judicial Panel on Multidistrict Litigation on September 24, 2009, in Richmond, Virginia. The Panel will evaluate whether consolidation is appropriate in the Hydroxycut litigation and determine which court will receive the cases.

If an MDL is formed, all pending cases will be transferred to one district for pretrial litigation. In addition, as additional cases are filed by Hydroxycut lawyers who are currently investigating potential claims, they will also be transferred to the MDL. If the cases do not settle or otherwise resolve during the pretrial proceedings, they will be returned back to the court where they were filed for trial.


1 Comments


GeeTee
Snake oil, pure and simple. In the good old days, charlatins like these would have been tarred-and-featherd and run out of town on a rail. It’s time someone stepped in and took control of these creeps and put them out of business in into prison, where they rightfully belong. Constantly taking advantage of the vain, the obese naive fools, who think “medical science” has just introduced a “miracle cure” for their problems are suckers for such phonies as these. Barnum was right. And our stupid public are proving that every second of every day.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

A Wisconsin woman has filed a Depo-Provera brain tumor lawsuit, alleging that she continued using the birth control injection for years after her diagnosis due to the manufacturers’ failure to provide adequate warnings about the potential risk of developing a meningioma.
Following the rapid expansion of legalized sports betting across the U.S., a new watchdog report reveals how the gambling industry lobbied against consumer protections to prevent sports betting addictions, while wagers reached $148 billion annually.
A group of 11 lawsuits over complications associated with Bard PowerPort and other implantable port catheters will be prepared for a series of early bellwether trials in the federal MDL.